Pick a job to read the details
Tap any role on the left — its description and apply link will open here.
Share this job
Aegis Ventures partners with entrepreneurs and industry leaders to launch and scale transformative companies in digital health and artificial intelligence. Our platform brings together market-shaping ideas, growth capital, and ambitious individuals to solve major societal problems. With a focus on innovations in healthcare, Aegis has launched four successful portfolio companies in partnership with Northwell Health and recently announced the Digital Consortium to co-develop, invest in, and launch new companies.
Wavelet Medical aims to revolutionize fetal health monitoring to eliminate preventable brain injuries at birth, reduce unnecessary C-sections, and improve outcomes for mothers and their babies. While traditional fetal heart rate monitoring is widely used, it has not meaningfully reduced brain injuries and has been linked to increased C-section rates.
Wavelet is building the first non-invasive electroencephalography (EEG) system to measure fetal brain activity during pregnancy and labor. Our technology combines novel sensing hardware with advanced signal processing and machine learning to extract clinically meaningful EEG signals from complex biological noise—enabling earlier, more accurate assessment of fetal neurological health without compromising maternal or fetal safety. This approach supports better clinical decision-making and healthier outcomes during childbirth.
We are a venture-backed, early-stage medtech company advancing toward FDA clearance of a Class II medical device.
As the Clinical Affairs Manager (Part-Time), you will lead clinical affairs and drive adoption of our breakthrough fetal monitoring technology. This role will be critical in bridging our innovative technology with clinical practice, supporting regulatory approval, and establishing hospital partnerships. This role will be up to 25 hours a month.
This is a part-time position (approximately 25 hours per month) and is remote within the U.S., with periodic travel required to clinical sites. We have a preference for candidates based in major metropolitan areas with access to academic medical centers.
Aegis Ventures is a proud Equal Opportunity Employer — we recruit, train, compensate and promote our team members based on qualifications. We encourage you to apply regardless of your race, religion, national origin, sex, gender identity, sexual orientation, disability, age, veteran status, or any other applicable legally protected characteristics.
Ready to apply?
Apply to Aegis Ventures
Share this job
Aegis Ventures partners with entrepreneurs and industry leaders to launch and scale transformative companies in digital health and artificial intelligence. Our platform brings together market-shaping ideas, growth capital, and ambitious individuals to solve major societal problems. With a focus on innovations in healthcare, Aegis has launched four successful portfolio companies in partnership with Northwell Health and recently announced the Digital Consortium to co-develop, invest in, and launch new companies.
Optain is a revolutionary healthcare company that uses groundbreaking clinicians, software, and hardware technology to rethink care. We use the eye as a window to the body to improve the way we screen, manage, and treat eye and systemic conditions. Optain is committed to expanding and improving care through a combination of our teleophthalmology clinical team, our AI and machine learning technology, and our best in class fundus camera. Optain targets front-line screening and new care settings at an accessible price. At a systemic level, this not only ensures greater access to care but also promises to reduce the strains of an overburdened healthcare system.
Optain’s recently closed Series A (led by major US private equity firms, strategic investors, and health systems) was done with the expectations of rapid commercial growth. Optain has achieved regulatory clearance and commercial adoption of its product suite in global markets, including Australia, the Middle East, and Europe, and is actively scaling across multiple health systems in the US.
As the Manager of Clinical Implementation, you will own the end-to-end clinical implementation journey for US customers—from contract signature through go-live and sustained early adoption. This role sits at the intersection of clinical operations, healthcare IT, and customer delivery, serving as the primary business owner for each implementation and the person accountable for ensuring customers successfully integrate Optain’s Resolve camera and cloud grading platform into their screening workflows.
Reporting to the Head of US Customer Success & Implementation, the Manager will partner closely with Technical Implementation & Support, the Customer Success team, Product Management, and Engineering to deliver a repeatable, scalable implementation process across Optain’s customer base–which includes large health systems, FQHCs, and smaller primary care practices. You will define screening workflows, support EHR integrations (Orders and Results), lead clinical staff training, and drive proof-of-concept KPIs toward target utilization.
This is a remote, US-based position requiring willingness to travel domestically up to 50% of the time for on-site implementations and go-lives.
Why Optain? Make a real difference: Your work will help solve difficult problems as you collaborate with world-class experts from healthcare provider networks, academia, and industry. Join Optain in transforming healthcare with AI!
Aegis Ventures is a proud Equal Opportunity Employer — we recruit, train, compensate and promote our team members based on qualifications. We encourage you to apply regardless of your race, religion, national origin, sex, gender identity, sexual orientation, disability, age, veteran status, or any other applicable legally protected characteristics.
Ready to apply?
Apply to Aegis Ventures
Cookies & analytics
This site uses cookies from third-party services to deliver its features and to analyze traffic.